COREG is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Carvedilol.
Product ID | 0007-4141_5d3c75e2-3d90-4263-b276-38330ad96a76 |
NDC | 0007-4141 |
Product Type | Human Prescription Drug |
Proprietary Name | COREG |
Generic Name | Carvedilol |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 1997-06-03 |
Marketing Category | NDA / NDA |
Application Number | NDA020297 |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | CARVEDILOL |
Active Ingredient Strength | 13 mg/1 |
Pharm Classes | Adrenergic alpha-Antagonists [MoA],Adrenergic beta1-Antagonists [MoA],Adrenergic beta2-Antagonists [MoA],alpha-Adrenergic Blocker [EPC],beta-Adrenergic Blocker [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 1997-06-03 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020297 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1997-06-03 |
Ingredient | Strength |
---|---|
CARVEDILOL | 12.5 mg/1 |
SPL SET ID: | c57982f2-c7da-488a-7ea9-b9609439ac68 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0007-3370 | COREG | carvedilol phosphate |
0007-3371 | COREG | carvedilol phosphate |
0007-3372 | COREG | carvedilol phosphate |
0007-3373 | COREG | carvedilol phosphate |
0007-3383 | COREG | carvedilol phosphate |
0007-3385 | COREG | carvedilol phosphate |
0007-3387 | COREG | carvedilol phosphate |
0007-3388 | COREG | carvedilol phosphate |
0007-4139 | COREG | carvedilol |
0007-4140 | COREG | carvedilol |
0007-4142 | COREG | COREG |
0007-4141 | COREG | COREG |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
COREG 74583051 2000337 Live/Registered |
SMITHKLINE BEECHAM LIMITED 1994-10-06 |